These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1361206)

  • 1. A metabolic assessment of the beta 1 selectivity of bisoprolol.
    Haffner CA; Horton RC; Lewis HM; Hughes B; Kendall MJ
    J Hum Hypertens; 1992 Oct; 6(5):397-400. PubMed ID: 1361206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the beta1-selectivity of three beta1-selective beta-blockers.
    Nuttall SL; Routledge HC; Kendall MJ
    J Clin Pharm Ther; 2003 Jun; 28(3):179-86. PubMed ID: 12795776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The beta-adrenoceptor subtype(s) mediating adrenaline- and dobutamine-induced blood pressure and heart rate changes in healthy volunteers.
    Daul A; Hermes U; Schäfers RF; Wenzel R; von Birgelen C; Brodde OE
    Int J Clin Pharmacol Ther; 1995 Mar; 33(3):140-8. PubMed ID: 7599912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effects of bisoprolol and atenolol on glucose metabolism in hypertensive patients with non-insulin-dependent diabetes mellitus].
    Vulpis V; Antonacci A; Prandi P; Bokor D; Pirrelli A
    Minerva Med; 1991 Apr; 82(4):189-93. PubMed ID: 1673233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment of angina pectoris with bisoprolol or atenolol in patients with chronic obstructive bronchitis: a randomized, double-blind crossover study.
    Dorow P; Thalhofer S; Bethge H; Disselhoff G; Wagner G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S36-44. PubMed ID: 11527135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta 1-adrenoceptor selectivity of single oral doses of bisoprolol and atenolol.
    Chang PC; van Veen S; van der Krogt JA; Vermeij P; van Brummelen P
    J Cardiovasc Pharmacol; 1988 Sep; 12(3):317-22. PubMed ID: 2464104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise-induced hand tremor: a possible test for beta 2-adrenoceptor selectivity in man?
    Abila B; Wilson JF; Marshall RW; Richens A
    Br J Clin Pharmacol; 1986 Jul; 22(1):104-7. PubMed ID: 2874824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of exercise tachycardia in man after propranolol, atenolol and bisoprolol in comparison to beta-adrenoceptor occupancy.
    Wellstein A; Palm D; Belz GG; Butzer R; Polsak R; Pett B
    Eur Heart J; 1987 Dec; 8 Suppl M():3-8. PubMed ID: 2897299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the receptor profile of bisoprolol.
    Klockow M; Greiner HE; Haase A; Schmitges CJ; Seyfried C
    Arzneimittelforschung; 1986 Feb; 36(2):197-200. PubMed ID: 2870719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of beta-1 selectivity of bisoprolol and atenolol by means of their influence on the lipolytic response to an infusion of terbutaline.
    Kendall MJ; Akhlaghi S; Haffner CA
    J Clin Pharm Ther; 1991 Feb; 16(1):25-9. PubMed ID: 1673971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta 1-selectivity of bisoprolol, a new beta-adrenoceptor antagonist, in anesthetized dogs and guinea pigs.
    Schliep HJ; Harting J
    J Cardiovasc Pharmacol; 1984; 6(6):1156-60. PubMed ID: 6084774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisoprolol in the treatment of chronic stable angina pectoris.
    Terol I; Plaza L; Rodrigo F
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S208-12. PubMed ID: 11527131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Atenolol and bisoprolol in the treatment of mild and moderately severe hypertension].
    Soucek M; Prásek J; Spinarová L
    Vnitr Lek; 1993 Jun; 39(6):541-8. PubMed ID: 8212607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiovascular response to mental and physical stress in hyper-reactive normotensive subjects. Beta blockade effect].
    Przybylski J; Resnik M; Corsi M; Suez V; Dervich R; Bevacqua R; Lachitiello J; Elizari M
    Medicina (B Aires); 2004; 64(5):390-4. PubMed ID: 15560538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind comparison of bisoprolol and atenolol in patients with essential hypertension.
    Wheeldon NM; MacDonald TM; Prasad N; Maclean D; Peebles L; McDevitt DG
    QJM; 1995 Aug; 88(8):565-70. PubMed ID: 7648243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dose-ranging study to evaluate the beta 1-adrenoceptor selectivity of bisoprolol.
    Lipworth BJ; Irvine NA; McDevitt DG
    Eur J Clin Pharmacol; 1991; 40(2):135-9. PubMed ID: 1676675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bisoprolol and atenolol on endurance exercise capacity in healthy men.
    Vanhees L; Defoor JG; Schepers D; Lijnen P; Peeters BY; Lacante PH; Fagard RH
    J Hypertens; 2000 Jan; 18(1):35-43. PubMed ID: 10678541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta adrenoreceptor subtype cross regulation in the human heart.
    Hall JA; Ferro A; Dickerson JE; Brown MJ
    Br Heart J; 1993 Apr; 69(4):332-7. PubMed ID: 8098220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac and vascular beta-adrenoceptor-mediated responses before and during treatment with bisoprolol or atenolol.
    Bolli P; Müller FB; Linder L; Ji BH; Bühler FR
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S61-4. PubMed ID: 2439800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is metoprolol CR/ZOK more selective than conventional metoprolol and atenolol?
    Kendall M; Akhlaghi S; Hughes B; Lewis H
    J Clin Pharmacol; 1990 Feb; 30(S2):S98-102. PubMed ID: 2155948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.